Group 1 - The core point of the article is the announcement of a share reduction plan by Zhejiang Haizheng Biological Materials Co., Ltd., where Sinopec Capital intends to reduce its holdings due to funding needs for business development [1] - As of February 24, 2026, Haizheng's stock closed at 13.46 yuan, with a market capitalization of 2.728 billion yuan, and a trading volume of 47.9582 million yuan [1] - Sinopec Capital holds 10,788,194 shares, representing 5.32% of the total share capital, and plans to reduce up to 2,026,700 shares, which is no more than 1% of the total share capital [1] Group 2 - The reduction period is set from March 17, 2026, to June 16, 2026, and the selling price will be determined by market conditions [1] - The share reduction will not lead to a change in the company's control or significantly impact its governance structure and ongoing operations [1]
海正生材(688203)披露股东减持股份计划公告,2月24日股价上涨0.75%